Karyopharm Therapeutics Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Karyopharm Therapeutics Inc.
CIK #0001503802
EDGAR Form CIK 2011 - 2025
10-K [0001503802]
10-Q [0001503802]
3 [0001503802]
4 [0001503802]
5 [0001503802]
8-K [0001503802]
D [0001503802]
SC 13D [0001503802]
SC 13G [0001503802]
Form 13D/13G Filer Form 13D/13G Subject Filed
T Rowe Price Investment Management Inc Karyopharm Therapeutics Inc [2025-08-14]
JPMorgan Chase & Co Karyopharm Therapeutics Inc [2025-07-16]
Affinity Asset Advisors LLC Karyopharm Therapeutics Inc [2025-04-10]
Adage Capital Management LP Karyopharm Therapeutics Inc [2025-02-12]
Highbridge Capital Management LLC Karyopharm Therapeutics Inc [2024-10-25]
J Wood Capital Advisors LLC Karyopharm Therapeutics Inc [2024-05-23]
Vanguard Group Inc Karyopharm Therapeutics Inc [2024-02-13]
Rubric Capital Management LP Karyopharm Therapeutics Inc [2023-02-10]
BlackRock Inc Karyopharm Therapeutics Inc [2023-01-20]
Avidity Partners Management LP Karyopharm Therapeutics Inc [2022-12-08]
View All
Form 3/4/5 Subject 2011 - 2025
Karyopharm Therapeutics Inc.
Poulton Stuart
Abate Kristin
Mirza Mansoor Raza
Greene Barry E
Pakianathan Deepika
Schor Chen
Bohlin Garen G
Su Zhen
Oliger Christy J.
View All
Terms | Privacy | Guide
tony@aum13f.com